Enhanced Antibacterial, Anti-Inflammatory, and Antibiofilm Activities of Tryptophan-Substituted Peptides Derived from Cecropin A-Melittin Hybrid Peptide BP100
Molecules · 2024
DOI: 10.3390/molecules29225231 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Sukumar Dinesh Kumar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cellular & Molecular Medicine, School of Medicine, Chosun University, Gwangju 61452, Republic of Korea. Hauptthemen laut MEDLINE: Biofilms, Anti-Bacterial Agents, Anti-Inflammatory Agents, Tryptophan. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chosun University.
Abstract (Originalsprache)
The emergence of multidrug-resistant pathogens necessitates the development of novel antimicrobial agents. BP100, a short α-helical antimicrobial peptide (AMP) derived from cecropin A and melittin, has shown promise as a potential therapeutic. To enhance its efficacy, we designed and synthesized 16 tryptophan-substituted BP100 analogs based on helical wheel projections. Among these, BP5, BP6, BP8, BP11, and BP13 exhibited 1.5- to 5.5-fold higher antibacterial activity and improved cell selectivity compared to BP100. These analogs demonstrated superior efficacy in suppressing pro-inflammatory cytokine release in LPS-stimulated RAW 264.7 cells and eradicating preformed biofilms of multidrug-resistant Pseudomonas aeruginosa (MDRPA). Additionally, these analogs showed greater resistance to physiological salts and serum compared to BP100. Mechanistic studies revealed that BP100 and its analogs exert their antibacterial effects through membrane disruption, depolarization, and permeabilization. Notably, these analogs showed synergistic antimicrobial activity with ciprofloxacin against MDRPA. Our findings suggest that these tryptophan-substituted BP100 analogs represent promising candidates for combating multidrug-resistant bacterial infections, offering a multifaceted approach through their antibacterial, anti-inflammatory, and antibiofilm activities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cellular & Molecular Medicine, School of Medicine, Chosun University, Gwangju 61452, Republic of Korea.
- Graduate School of Biomedical Science, Chosun University, Gwangju 61452, Republic of Korea.
- Division of Magnetic Resonance, Korea Basic Science Institute (KBSI), Ochang 28119, Republic of Korea.
- Department of Microbiology, School of Medicine, Chosun University, Gwangju 61452, Republic of Korea.
- Institute of Well-Aging Medicare & CSU G-LAMP Project Group, Chosun University, Gwangju 61452, Republic of Korea.
ORCID-Profile: Sukumar Dinesh Kumar, Naveen Kumar Radhakrishnan, Jeong Kyu Bang, Song Yub Shin
Förderung
- Chosun University
Zitieren
APA
Kumar, S. D., Kim, E. Y., Radhakrishnan, N. K., Bang, J. K., Yang, S., & Shin, S. Y. (2024). Enhanced Antibacterial, Anti-Inflammatory, and Antibiofilm Activities of Tryptophan-Substituted Peptides Derived from Cecropin A-Melittin Hybrid Peptide BP100. Molecules. https://doi.org/10.3390/molecules29225231
Vancouver
Kumar SD, Kim EY, Radhakrishnan NK, Bang JK, Yang S, Shin SY. Enhanced Antibacterial, Anti-Inflammatory, and Antibiofilm Activities of Tryptophan-Substituted Peptides Derived from Cecropin A-Melittin Hybrid Peptide BP100. Molecules. 2024. doi:10.3390/molecules29225231
BibTeX
@article{Kumar2024,
author = {Kumar, Sukumar Dinesh and Kim, Eun Young and Radhakrishnan, Naveen Kumar and Bang, Jeong Kyu and Yang, Sungtae and Shin, Song Yub},
title = {Enhanced Antibacterial, Anti-Inflammatory, and Antibiofilm Activities of Tryptophan-Substituted Peptides Derived from Cecropin A-Melittin Hybrid Peptide BP100},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29225231}
}
EUVIMED